Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: A double-blind, placebo-controlled study

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 55, Issue 9, 2000, Pages 842-849

  Pajno, Giovanni Battista ^a,c   Morabito, L ^a   Barberio, G ^a   Parmiani, S ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b ALK Abello SpA   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

Asthma; Dust mite allergy; Sublingual immunotherapy (SLIT)

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; PLACEBO;

ADOLESCENT; ALLERGIC ASTHMA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG UTILIZATION; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; LONG TERM CARE; MALE; MITE; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ALLERGENS; ANIMALS; ASTHMA; CHILD; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; DUST; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; MITES; SKIN TESTS; TREATMENT OUTCOME;

EID: 0033898123     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2000.00495.x     Document Type: Article

References (35)

1. Allergy in asthma. II. The highly atopic infant and chronic asthma
2. Sensitization to inhalant allergens in wheezing infants is predictive of the development of infantile asthma
3. Mucosal inflammation in asthma
4. Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy
5. A controlled dose-response study of immunotherapy with standardized partially purified extract of house dust mite: Clinical efficacy and side effects
6. Controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with asthma
7. Safety considerations in assessing the role of immunotherapy in allergic disorders
8. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. IV. Systemic reactions according to the immunotherapy schedule
9. WHO Position Paper. Allergen immunotherapy: Therapeutical vaccines for allergic diseases
10. Local Immunotherapy. Position Paper by the Working Group on Local Immunotherapy of the EAACI Subcommittee and the ESPACI Immunotherapy Subcommittee
11. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double blind study
12. Sublingual immunotherapy in Parietaria pollen induced rhinitis: A double blind study
13. A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract
14. Clinical efficacy of sublingual-swallow immunotherapy: A double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis
15. Safety and efficacy of sublingual rush immunotherapy with grass allergen extract. A double-blind study
16. Sublingual versus injective immunotherapy in grass pollen allergic patients: A double blind (double dummy) study
17. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis
18. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization
19. Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: A double-blind, placebo-controlled study
20. Guidelines for the diagnosis and management of asthma. Expert Panel Report
21. EAACI Position Paper. Immunotherapy
22. Collaborative clinical assay of the biological potency of allergen skin test extracts
23. Position paper. Allergen standardization and skin tests
24. Cuantificacion de los alergenos Der p 1 y Der f 1 de los acaros del polvo domestico y Fel d 1 de gato mediante una ELISA en fase solida
25. The oral administration of pollen
26. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D. pt.) in children
27. A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract
28. Immunotherapy with sublingual birch pollen extract. A short term double-blind placebo study
29. Low dose sublingual therapy in patients with allergic rhinitis and asthma due to house dust mite
30. Diagnosis and immunotherapy of mould allergy. VII. IgG subclass response and relation to clinical efficacy of immunotherapy with Cladosporium
31. Sublingual immunotherapy
32. Estudio multicentrico de farmacovigilancia de inmunoterapia sublingual en pacientes alergicos
33. Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings